PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION
https://doi.org/10.20996/1819-6446-2009-5-4-33-38
Abstract
Aim. To study effects of bioflavonoid quercetin (corvitin) on left ventricle (LV) systolic dysfunction in patients with acute coronary syndrome with ST segment elevation (ACS+ST) after cardiac revascularization.
Material and methods. 60 patients with ACS+ST (44,2±1,3 y.o.) were examined. Patients were admitted to hospital within 6 hours after complaints beginning. Patients were randomized in two groups. 30 patients of group A had standard therapy and cardiac revascularization. 30 patients of group B received corvitin additionally to standard therapy before cardiac revascularization. Echocardiography initially and stress-echocardiography with dobutamine after status stabilization (at 8-10 days of disease) were performed.
Results. Dobutamine test (with low and high doses) showed myocardial viability in patients of group B. Patients of group A had irreversible LV systolic dysfunction in 32 % of segments. Corvitin slowed down LV dilatation progression in patients with ACS+ST. It resulted in the end-diastolic and end-systolic indexes did not change within 10 days. The LV ejection fraction was more increased in patients of group B in comparison with patients of group A.
Conclusion. The early corvitin prescribing has positive effects on LV systolic function and prevents post-reperfusion complications.
About the Authors
A. L. Alyavi
Republic Research Center for Urgent Medical Care
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
B. A. Alyavi
Republic Research Center for Urgent Medical Care
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
M. L. Kenzhaev
Republic Research Center for Urgent Medical Care
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
S. R. Kenzhaev
Republic Research Center for Urgent Medical Care
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
Uzbekistan
Farhadskaya ul. 2, Chilansarskiy rayon, Tashkent 100071
References
1. Redwood S.R., Ferrari R., Marber M.S. Myocardial hibernation and stunning: from physiological principles to clinical practice. Heart. 1998;80(3):218-22.
2. Литвицкий П.Ф., Сандриков В.А., Демуров Е.А. Адаптивные и патогенные эффекты реперфузии и реоксигенации миокарда. М.: Медицина; 1994.
3. Smart S.C., Sawada S., Ryan T. et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
4. Zaret B.L., Wackers F.J., Terrin M.I. et al. Assessment of global and ventricular perfomance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) II Study. Am J Cardiol 1992;69:1-9.
5. Sanchis J., Munos J., Chorro F.J. et al. Stunned myocardium after thrombolytic treatment. Identification by dobutamine echocardiography and role of the residual stenosis in the infarction artery. Int J Cardiol 1996;53:5-13.
6. Nijland F., Kamp O., Verhorst P.M. et al. Myocardial viability: impact on left ventricular dilatation after acute myocardial infarction. Heart 2002;87(1): 17-22.
7. Reduto LA., Smalling R.W., Freund G.G., Gould K.L. Intracoronary infusion of streptokinase in patients with acute myocardial infarction: effects of reperfusion on left ventricular performance. Am J Cardiol 1981;48:403-9.
8. Stack R.S., Phillips H.R. 3rd, Grierson D.S., et al. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J CIin Invest 1983;72:84-95.
9. Schmidt W.G., Sheehan F.H., von Essen R. et al. Evolution of left ventricular function after intracoronary thrombolysis for acute myocardial infarction. Am J Cardiol 1989;63:497-502.
10. Huk I., Brovkovych V., Nanobash Vili J. et al. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surg 1998;85(8):1080-5.
11. Moibenko A.A., Maxyutina N.P., Mochort N.A., et al. Lipoxygenase and no synthase activities following of acute myocardial infarction. New aspects of treatment (abstract). Pathophysiology 1998;5 Suppl 1:9.
Review
For citations:
Alyavi A.L., Alyavi B.A., Kenzhaev M.L., Kenzhaev S.R. PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION. Rational Pharmacotherapy in Cardiology. 2009;5(4):33-38. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-4-33-38
Views:
691
Email this article 